Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?

Aberrant activity of tyrosine kinases has been proved to be associated with multiple diseases including fibrotic diseases. Tyrosine kinases inhibitors (TKIs) might be a novel approach to transform the anti-fibrotic treatment. However, both beneficial and adverse effects are observed by researchers w...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Qu, Kai, Liu, Tian, Lin, Ting, Zhang, Xing, Cui, Ruixia, Liu, Sinan, Meng, Fandi, Zhang, Jingyao, Tai, Minghui, Wan, Yong, Liu, Chang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341902/
https://ncbi.nlm.nih.gov/pubmed/27588502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11767
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi